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The tyrosine kinase Met, the product of the
c-met proto-oncogene and the receptor for
hepatocyte growth factor/scatter factor (HGF/
SF), mediates signals critical for cell survival
and migration. The human pathogen Listeria
monocytogenes exploits Met signaling for inva-
sion of host cells via its surface protein InlB. We
present the crystal structure of the complex
between a large fragment of the human Met
ectodomain and the Met-binding domain of
InlB. The concave face of the InlB leucine-rich
repeat region interacts tightly with the first
immunoglobulin-like domain of the Met stalk,
a domain which does not bind HGF/SF. A sec-
ond contact between InlB and the Met Sema
domain locks the otherwise flexible receptor in
a rigid, signaling competent conformation. Full
Met activation requires the additional C-termi-
nal domains of InlB which induce heparin-medi-
ated receptor clustering and potent signaling.
Thus, although it elicits a similar cellular re-
sponse, InlB is not a structural mimic of HGF/SF.
INTRODUCTION
Pathogenic bacteria have evolved elaborate ways to
subvert host cell signaling pathways to their own benefit
(Galan, 2000). The facultative intracellular Gram-positive
pathogen Listeria monocytogenes has at its disposal two
surface molecules of the internalin family that engage
the extracellular region of human receptors to relay signals
across the membrane into the host cell cytoplasm. Recep-
tor activation induces rearrangements of the actin cyto-
skeleton and ultimately causes bacterial invasion of
normally nonphagocytic cells. The cytoplasm constitutes
a protected niche where L. monocytogenes can replicate
and spread to cause systemic disease (Hamon et al.,
2006).The intestinal epithelium forms the first barrier that
L. monocytogenes encounters following uptake with
contaminated food. Binding of InlA, also called internalin,
to E-cadherin exposed at the tip of intestinal villi initiates
uptake of bacteria into epithelial cells, enabling them to
breach this barrier (Gaillard et al., 1991; Lecuit et al.,
2001; Mengaud et al., 1996; Pentecost et al., 2006). Colo-
nization of deeper tissues requires the related protein InlB
that mediates uptake into a number of cell types including
hepatocytes and endothelial cells (Braun et al., 1998;
Dramsi et al., 1995; Parida et al., 1998).
InlB is a bacterial surface protein of 630 amino acids. It
shares with InlA the organization of the N-terminal inter-
nalin domain comprising a Cap, a variable number of
leucine-rich repeats (LRRs) and a so-called interrepeat
(IR) region (Schubert and Heinz, 2003; Figure 1A). A poorly
characterized B-repeat is followed by three C-terminal
GW domains that noncovalently anchor InlB on the sur-
face of Listeria through interaction with lipoteichoic acid
(Braun et al., 1997; Jonquieres et al., 1999). In addition
to the bacteria-bound form, a substantial fraction of InlB
is released into the medium as a soluble molecule and
elicits a cellular response reminiscent of that caused by
hepatocyte growth factor/scatter factor (HGF/SF; Braun
et al., 1997; Ireton et al., 1999). This observation contrib-
uted to the identification of the receptor tyrosine kinase
Met as receptor for InlB (Shen et al., 2000). Normally,
HGF/SF and Met mediate signals critical for cell survival
and migration in embryogenesis and tissue regeneration,
but deregulation of Met also plays a major role in tumor
invasion (Birchmeier et al., 2003). Two further receptors
for InlB have been described, the complement receptor
gC1qR (Braun et al., 2000) and heparan sulfate proteo-
glycans (HSPGs; Jonquieres et al., 2001). While the exact
function of gC1qR is still under debate, it is clear now that
HSPGs significantly enhance InlB-induced Met signaling
(Banerjee et al., 2004; Jonquieres et al., 2001).
InlB is structurally well characterized (Marino et al.,
1999, 2002; Schubert et al., 2001), and the interaction
sites for all three receptors are known. A fragment com-
prising Cap and LRR (InlB241; Figure 1A) is sufficient for
Met binding (Shen et al., 2000), and InlB321, a fragmentCell 130, 235–246, July 27, 2007 ª2007 Elsevier Inc. 235
Figure 1. Mapping of Met Domains Required for Binding of InlB
(A) Domain organization of InlB. The internalin domain (residues 36 to 321) cocrystallized with Met is shown in color.
(B) Domain organization of Met and constructs of the ectodomain used in this study.
(C) Domain organization of HGF/SF. N: N-domain; K1–K4: kringle1–kringle4. SPH: serine protease homology domain. Experimentally proven inter-
actions of individual HGF/SF domains with Met are indicated by arrows.
(D) SDS-PAGE of purified Met constructs. Under nonreducing conditions (left) the proteins run as a single, disulfide-linked species. Under reducing
conditions (right) they split into a- and b chain. The a chain doublet is due to heterogenous glycosylation.
(E) InlB321 does not bind immobilized Met567 in a solid phase binding assay. Data show mean and standard deviation of a representative experiment
with each data point measured in triplicate.
(F) Immobilized Met928, Met838, and Met741 bind soluble InlB321 with identical apparent affinities. Data show mean and standard deviation of three
independent experiments with each data point measured in duplicate or triplicate in a single experiment. Independent experiments were normalized
to maximum binding.further comprising the IR region, is the minimal fragment
capable of receptor activation (Banerjee et al., 2004).
The Met-binding site maps to the concave face of the
LRR region where several aromatic amino acids essential
for interaction with Met are located (Machner et al., 2003).
In addition to their interaction with lipoteichoic acid, the
highly basic GW domains bind gC1qR and HSPGs, and
binding of these receptors to the C terminus of InlB is
competitive (Jonquieres et al., 2001; Marino et al., 2002).
Less is known about the six domains of the Met ectodo-
main that comprise some 900 amino acids (Birchmeier
et al., 2003). Met is produced as a 1390 amino acid
single-chain precursor that is cleaved by the cellular
protease furin between residues 307 and 308 to yield a
disulfide-linked two-chain heterodimer (Figure 1B). The236 Cell 130, 235–246, July 27, 2007 ª2007 Elsevier Inc.completely extracellular a chain, together with amino
acids 308–514 of the b chain, forms the N-terminal sema-
phorin (Sema) domain. The b chain further contains a small
cysteine-rich (PSI) and four immunoglobulin-like domains
(Ig1–Ig4), a transmembrane helix and the cytoplasmic
juxtamembrane and tyrosine kinase domains. The Sema
domain, a seven-bladed b-propeller, includes the binding
site for the HGF/SF b chain (Figure 1C) (Stamos et al.,
2004). Two of the five domains within the HGF/SF a chain
bind to Sema as well (Holmes et al., 2007). The Met Ig do-
mains do not bind HGF/SF and have been proposed to act
as a stalk presenting the ligand binding Sema domain
(Gherardi et al., 2003). The crystal structure of the
Sema-PSI fragment in complex with the HGF/SF b chain
has been determined (Stamos et al., 2004), and homology
Figure 2. The Structure of the Met741-InlB321 Complex Reveals Two Interfaces that Are Both Distinct from that for the HGF/SF
b Chain
(A) Cartoon representation of the complex. Coloring as in Figures 1A and 1B.
(B) Side view of the complex. Ig2 is not present in the final model. The domain shown in gray is a homology model of Ig2, the position of which was
determined by molecular replacement.
(C) Open book view of the complex in surface representation (Ig2 is omitted). Residues in the interface were colored according to the degree of burial
upon complex formation. Light-orange: up to 30% reduction of accessible surface area (ASA). Orange: 31%–80% reduction of ASA. Brown: >80%
reduction of ASA. Atoms forming intermolecular hydrogen bonds are shown in cyan, and atoms forming intermolecular salt bridges are shown in
magenta. Interface analysis was carried out with the PISA server (Krissinel and Henrick, 2005).
(D) The binding site of the HGF/SF b chain (pink) is distinct from the InlB binding sites. Overlay of the Met-InlB complex with that of the HGF/SF b chain
in complex with Met567 (Stamos et al., 2004). The overlay was performed on the Sema domain. The b-propeller is viewed from the bottom, and the
blades are numbered. The Sema domain of the Met-InlB complex is shown in light-brown for the Met a chain and in yellow for the Met b chain. Met
from the HGF/SF-Met complex is in gray. The different positions of two spheres representing the Ca positions of the C-terminal cysteine in the PSI
domain indicate the large rearrangement of this domain relative to Sema.models are available for the Met Ig domains (Gherardi
et al., 2003). The InlB-binding site on Met is so far
unknown, but it appears to be distinct from that for HGF/
SF as no competition for binding to Met was observed
(Shen et al., 2000).
Here we map the InlB-binding domains of Met and
report two crystal structures of a Met-InlB complex. The
structures provide a detailed picture of the interaction
between the two proteins and, combined with solution
studies with full-length InlB, they explain the mechanism
by which full-length InlB activates the Met receptor.
RESULTS
At Least One Ig Domain of Met Is Crucial for Binding
of InlB321
To map the InlB-binding site on Met we used four
recombinant variants of the Met ectodomain (Figures 1Band 1D) purified from conditioned medium of stably trans-
fected, gylcosylation-deficient CHO Lec cells. In solid-
phase binding assays, InlB321 did not show high-affinity
binding to Met567, a construct comprising only the Sema
and PSI domains (Figure 1E). In contrast, InlB321 bound
with high- and virtually identical affinity to longer variants
of the Met ectodomain (Met741, Met838, and Met928) that
contain two, three, or four immunoglobulin (Ig)-like do-
mains, respectively (Figure 1F). Thus, the binding site for
InlB321 is fully included in Met741 but not in Met567, imply-
ing a critical role of the Ig1 and/or Ig2 domains of Met for
binding the bacterial ligand.
InlB Binds Met via Two Interfaces Different
from the Binding Site for the HGF/SF b Chain
We crystallized the complex between InlB321 and Met741,
the shortest Met construct that retained high-affinity bind-
ing, in two different crystal forms. Crystal form I with twoCell 130, 235–246, July 27, 2007 ª2007 Elsevier Inc. 237
complexes in the asymmetric unit contained enzymati-
cally deglycosylated Met and diffracted to 2.8 A˚. Crystal
form II in a different space group contained Met with trun-
cated N-linked carbohydrate side chains produced by the
Lec3.2.8.1 mutant of CHO cells (Stanley, 1989). These
crystals diffracted to 4 A˚ and also contain two complexes
in the asymmetric unit. Both crystal forms were solved by
molecular replacement. We used crystal form II only to
compare the overall domain arrangement with that of the
better diffracting and more extensively refined crystal
form I discussed below.
In crystal form I, we modeled the first three Met
domains: Sema, PSI, and Ig1, all of which are in direct
contact with InlB (Figures 2A and 2B). Ig2 does not contact
InlB, and there is no continuous electron density for this
domain. It is, therefore, omitted from the final model. Nev-
ertheless, we could place by molecular replacement an
Ig2 homology model (Gherardi et al., 2003) that is shown
in Figures 2A and 2B. InlB interacts with Met via two inter-
faces. A contact between the concave face of the InlB LRR
region and Met Ig1 forms the primary interface (Figure 2C),
in agreement with the binding data generated with domain
deletion constructs of Met (Figures 1E and 1F) or point
mutants of InlB (Machner et al., 2003). The secondary,
less extensive contact involves the InlB IR region and
the Sema domain of Met (Figure 2C) and had not been pre-
dicted by binding studies.
Like the InlB IR region, the b chain of HGF/SF contacts
the Sema domain on the bottom face of the b-propeller
(Stamos et al., 2004). However, the binding sites for the
two ligands on the Sema domain are distant and do not
overlap (Figure 2D). The HGF/SF b chain contacts the
Met a chain at blade 2 and 3 of the Sema domain, whereas
InlB contacts the Met b chain at blades 4 to 6. This agrees
with the observation that full-length InlB and HGF/SF can
bind Met simultaneously (Shen et al., 2000). Apart from the
b chain, HGF/SF has additional domains that interact with
Met. To test for a potential overlap of other HGF/SF-bind-
ing sites on Met with that of InlB, we performed more
extensive competition experiments. These revealed a
concentration-dependent, partial competition between
InlB321 and full-length HGF/SF, but neither ligand could
displace the other completely (Figure S1).
Flexibility in the Met Ectodomain
The structure of InlB321 within the complex with Met is
virtually identical to several structures of free ligand (Marino
et al., 1999, 2002; Schubert et al., 2001). In contrast, Met
undergoes major rearrangements in order to bind InlB as
demonstrated by the fact that the relative orientation of
the Met Sema and PSI domain is radically different in the
Met741-InlB321 complex and in the complex of Met567 with
the b chain of HGF/SF (Stamos et al., 2004). Indeed, upon
aligning the Sema domains of the two structures, the C-
terminal end of the PSI domain is displaced by some 15 A˚
(Figure 2D). The movement can be described as a rigid
body rotation of roughly 60 around an axis close to the
linker between the two domains (Figure 3A). Two closely238 Cell 130, 235–246, July 27, 2007 ª2007 Elsevier Inc.spaced glycine residues (G517 and G519) provide suffi-
cient flexibility to make this linker an effective hinge region.
As both of our crystal forms contain two complexes per
asymmetric unit, there are four crystallographically inde-
pendent copies of the complex. We have applied tight
noncrystallographic symmetry (NCS) restraints through-
out refinement, but each domain was treated as a separate
NCS group. This allows us to asses the interdomain flexi-
bility within the Met741-InlB321 complex. The two com-
plexes in crystal form I are almost identical. This is not
surprising, as the NCS in crystal form I is very close to
a crystallographic symmetry and may merely represent
Figure 3. Flexibility of the Free Met Ectodomain versus Rigid-
ity of the Complex with InlB321
(A) Overlay of the Met741-InlB321 complex (coloring as in Figure 2) with
Met567 from the complex with the HGF/SF b chain (pink). The struc-
tures were aligned on the PSI domain to visualize the large relative
rearrangement of the Sema domain.
(B) Overlay of the Met-InlB complex from crystal form I (coloring as in
Figure 2) and from crystal form II (pink). The structures were aligned on
InlB. The Met Ig1 and PSI domains and the InlB-proximal side of the
Sema domain align very well. The secondary interface between the
InlB IR and the Met Sema domain is preserved.
Figure 4. The Primary Interface between InlB LRR and Met Ig1
(A) The InlB LRR embraces only the top of Met Ig1 with the unusual b-wing of the long B-C loop. The LRRs are numbered, and the strands in Ig1 are
labeled. Exposed aromatic side chains at the concave face of the InlB LRR and the disulfide bond connecting strands D and E of Met Ig1 are shown as
sticks.
(B) Close-up showing InlB Y170i and Y214i interacting with K599M and K600M of Met. Y170i makes hydrogen bonds (dotted orange lines) to the
carbonyl of K599M and the R602M side chain. The side chains of K599M and K600M are held in place by an intra- and intermolecular salt bridge (dotted
purple lines), respectively.
(C) Side chains of residues from b strands C, F, and G of the Met Ig1 domain form a hydrophobic pocket into which W124i from the concave face of the
InlB LRR binds.
(D) Electrostatic potential of InlB321 (left) and Met (right; Ig2 omitted). In the open-book view, the surfaces involved in binding are shown for both
proteins. The negative charges (red) on the InlB LRR face positive charges (blue) on Met Ig1.the breakdown of this perfect symmetry. The two copies in
crystal form II are truly independent of each other and of
the complex from crystal form I. Nevertheless, the overall
domain arrangement of the complexes from crystal form II
is similar to that of crystal form I, and the secondary inter-
face between the InlB IR region and the Met Sema domain
is preserved. An overlay of the complexes performed on
InlB shows that the Ig1 domain, the PSI domain, and the
InlB-proximal side of the Sema domain overlap very well
and that large movements are limited to Ig2 and the
InlB-distal side of the Sema domain due to a crystal lattice
contact (Figure 3B).
Details of the Primary Interface between the InlB LRR
Region and Met Ig1
Met741 is the largest fragment of the Met ectodomain crys-
tallized to date, and the structure of the Met Ig1 domain
has not been reported before, except for a homology
model (Gherardi et al., 2003). Ig1 is an immunoglobulin-
like domain with a disulfide bridge linking strands D andE. An unusually long B-C loop forms a unique b-hairpin
extending from the core (Figure 4A). The hairpin, which
we term b-wing, is a key element for InlB binding. The b-
wing lies at the center of the primary interface between
the concave face of the InlB LRR and Met Ig1 in which
some 1700 A˚2 of surface area are buried.
The LRR-Ig1 contact is reminiscent of InlA that likewise
binds the Ig-like domain EC1 of human E-cadherin in the
void of its larger, horseshoe-shaped LRR (Schubert
et al., 2002). However, unlike EC1, which is located cen-
trally within the LRR of InlA, the core of Met Ig1 is offset
by some 16 A˚ toward the loops connecting the 310-helices
and b strands of the InlB LRR (Figure 4A). Only the b-wing
and the top of the Ig fold are in direct contact with the
ligand. Two potential glycosylation sites are located at
the bottom of Ig1, implying that the carbohydrate side
chains present in native Met should neither interfere with
nor participate in ligand binding.
Overall, the LRR-Ig1 interface has a mixed hydrophobic
and polar character. A string of aromatic amino acid sideCell 130, 235–246, July 27, 2007 ª2007 Elsevier Inc. 239
chains is surface exposed on the concave face of the InlB
LRR. Acting as paddles, these residues engage in recep-
tor binding. The aromatic ring of the centrally located
Y170i (i denoting residues from InlB and M from Met)
stacks and packs, laterally, against the aliphatic side
chains of lysines K600M and K599M, respectively. Through
its hydroxyl group Y170i forms additional polar contacts to
the side chain of R602M and the backbone carbonyl of
K599M from the base of the b-wing (Figure 4B). K599M
also stacks against Y214i. The side chains of K599M and
K600M are held in place by an intra- and an intermolecular
salt bridge, respectively. Side chains from the b sheet
formed by strands CFG of Ig1 shape a hydrophobic
pocket for W124i (Figure 4C). The side chains of Phe104i
and Phe126i are completely buried upon complex forma-
tion, mainly by residues from the F-G loop, especially
G643M and G645M. These findings are in good agreement
with the results of previous mutational analysis highlight-
ing the functional importance of these aromatic InlB resi-
dues for Met binding (Machner et al., 2003). Complemen-
tary electrostatics between R592M and K600M from the tip
and the base of the b-wing, respectively, and a patch of
three acidic residues in the LRR region (D128i, E129i,
E150i) further contribute to the interaction (Figure 4D).
The PSI domain of Met contributes to the primary contact
a single hydrogen bond to the LRR of InlB.
The Secondary Interface between the InlB IR and Met
Sema Domain Is Critical for Receptor Activation
The second, less prominent contact between InlB IR and
Met Sema buries some 870 A˚2 and is mainly polar. The
overall strength of the interaction between the IR and
Sema domains is low, as we did not observe binding of
InlB321 to Met567, which can form the secondary, but not
the primary, contact (Figure 1E). Moreover, the secondary
interface does not measurably contribute to the binding
affinity of InlB321 to Met, as the shorter InlB241
(Figure 1A) that is only capable of binding Ig1 has an ap-
parent affinity for Met similar to InlB321 (Figure 5A). This un-
derscores that LRR-Ig1 is the primary, affinity-determining
contact. However, InlB241 and InlB321 show clear differ-
ences in terms of Met activation. InlB241 cannot induce
Met phosphorylation or Met-dependent activation of
Erk1/2 (Banerjee et al., 2004; Figure. 5B), whereas
InlB321 is active in these assays, highlighting the fact that
the interaction between the IR and Sema domains is
essential for the ability of InlB to activate Met.
Full-Length InlB Induces Receptor Clustering
in the Presence of Heparin
Full-length InlB (InlBfl) is much more active than InlB321 in
receptor phosphorylation assays and, like HGF/SF, it
elicits full cell responses such as cell migration (Banerjee
et al., 2004; Shen et al., 2000) or DNA synthesis in target
cells, which InlB321 cannot induce (Figures 5C and 5D).
Receptor dimerization, or more generally oligomerization,
is important in the activation of most receptor tyrosine
kinases (Hubbard and Till, 2000; Schlessinger, 2000).240 Cell 130, 235–246, July 27, 2007 ª2007 Elsevier Inc.Therefore, we analyzed the oligomerization properties of
InlB321 and InlBfl and their complexes with Met928, a solu-
ble form of the Met receptor encompassing the whole
ectodomain (Figure 1B) in the absence or presence of
Figure 5. The Secondary Interface Is Required for Activation
but Not for Binding
(A) InlB241 and InlB321 bind to Met928 with identical apparent affinity in
a solid phase binding assay. Data show mean and standard deviation
of three independent experiments with each data point measured in
triplicate in a single experiment. Independent experiments were
normalized to maximum binding.
(B) InlB321, but not InlB241, induces phosphorylation of ERK, a down-
stream target of Met. HGF/SF was used as positive control, and the
binding-deficient F104S mutant of InlB321 (Machner et al., 2003) was
used as negative control.
(C) Like HGF/SF, InlBfl induces scattering of MDCK colonies. The
shorter InlB variants do not.
(D) Like HGF/SF, InlBfl induces DNA synthesis in MK keratinocytes, but
the shorter InlB variants are inactive. Error bars represent standard
deviation.
Figure 6. Heparin Induces Clustering of Met in Complex with InlBfl, but Not with InlB321
Velocity sedimentation analysis with data expressed as a plot of dc/dt vs s20,w. Note the differences in x- and y-scale between different panels.
(A) Velocity sedimentation analysis of InlB321 (3 mM).
(B) Velocity sedimentation analysis of InlB321 (3 mM) with a 2-fold excess of dp12 heparin.
(C) Velocity sedimentation analysis of the Met928-InlB321 complex (3 mM).
(D) Velocity sedimentation analysis of the Met928-InlB321 complex (3 mM) with a 2-fold excess of dp12 heparin.
(E) Velocity sedimentation analysis of InBfl (3 mM).
(F) Velocity sedimentation analysis of InBfl (3 mM) with a 2-fold excess of dp12 heparin.
(G) Velocity sedimentation analysis of the Met928-InlBfl complex (2 mM).
(H) Velocity sedimentation analysis of the Met928-InlBfl complex (2 mM) with a 2-fold excess of dp12 heparin.a heparin 12-mer, in view of reports demonstrating that
the GW domains of InlB bind heparin and HSPGs (Bane-
rjee et al., 2004; Jonquieres et al., 2001). We used analyt-
ical ultracentrifugation (AUC), as complexes of InlBfl with
its receptor(s) are hardly tractable by size exclusion chro-
matography due to strong interactions of InlBfl with the
matrix at physiological salt concentrations.
InlB321 is monomeric (Figure 6A) and equimolar mix-
tures of InlB321 and Met928 produced a 1:1 complex and
a very small faster boundary (Figure 6C) that is also visible
on sedimentation of Met alone (Figure S2). Addition of
heparin did not change the sedimentation behavior of
InlB321 alone (Figure 6B) or in complex with Met928
(Figure 6D). Hence, under none of the conditions tested
did we observe dimerization of Met upon binding of
InlB321.
InlBfl alone sediments as a monomer (Banerjee et al.,
2004; Figure 6E). Addition of heparin caused extensive
aggregation and pelleting of the protein with just 20% of
the original material remaining in solution as a 1:1 InlBfl-
heparin complex (Figure 6F). InlBfl and Met928 at 1:1 molar
ratio gave a broad peak containing the 1:1 and 2:2 com-
plexes as well as smaller amounts of higher molecular
weight species (Figure 6G). Addition of heparin had a strik-
ing effect. The low molecular weight species disappeared,
and most of the material shifted to large sedimentationcoefficients (Figure 6H). Thus, heparin induced massive
clustering of the Met-InlBfl complexes, in striking contrast
with the results obtained with mixtures of HGF/SF and
Met928 (Gherardi et al., 2003).
DISCUSSION
InlB321 Acts as a ‘‘Molecular Clamp’’ to Lock Met
in a Signaling-Competent Conformation
Electron microscopy has shown that in the absence of
ligand, the Met ectodomain is highly flexible (Gherardi
et al., 2006). The large relative rearrangement of the
Sema and the PSI domain between the Met-InlB complex
and the complex of Met and the HGF/SF b chain confirms
these findings. In the latter complex, the Met PSI domain is
not constrained by interactions with the ligand. Therefore,
the orientation of the PSI domain does not represent a
specific HGF/SF-bound conformation. Rather, it will rep-
resent one of potentially many conformations that can
be sampled by the free Met ectodomain.
In contrast, in the Met-InlB complex the position of the
PSI domain is restricted through extensive contacts of
its two flanking domains, Sema and Ig1, with the ligand
InlB. InlB321 itself is a rigid unit that hardly changes upon
binding to Met. It thus presents a preformed binding site
to which the receptor accommodates. We suggest thatCell 130, 235–246, July 27, 2007 ª2007 Elsevier Inc. 241
Figure 7. Model of InlB-Mediated Met Activation by Receptor Clustering
(A) Model of Met activation by full-length InlB. All domains shown in surface representation are drawn to scale. InlB321 is shown in light green (Cap),
light blue (LRR), and dark blue (IR). Met is shown in yellow (Sema, containing the whole a chain), orange (PSI), red (Ig1), gray (Ig2 to Ig4), and purple for
the intracellular juxtamembrane (JM) and tyrosine kinase (TK) domain. The position of the GW domains was derived by aligning InlBfl (Marino et al.,
2002) with InlB321 in the complex. InlBfl bound to the bacterial surface could activate Met by clustering.
(B) The GW domains of soluble InlBfl induce clustering via interaction with heparan sulfate proteoglycans (HSPGs) present on the host cell.InlB acts as a ‘‘molecular clamp’’ that forces the otherwise
flexible receptor into a rigid, signaling-competent confor-
mation. This interpretation provides an explanation for the
fact that InlB321 but not the shorter InlB241 can induce Met
and Erk phosphorylation. Both proteins can bind the Ig1
domain of the receptor, but the lack of the IR domain
abrogates the ability of InlB241 to clamp Met into a signal-
ing-competent conformation via the second interface.
Currently we cannot draw definite conclusions about
how the intracellular signaling is initiated upon binding of
InlB321 to the extracellular part of Met. However, it is plau-
sible that the rigidification of the Met ectodomain allows
receptor molecules in the membrane to pack more
closely, which in turn may facilitate crossphosphorylation
of the cytoplasmic tyrosine kinase domains.
Full-Length InlB Activates Met
by Receptor Clustering
There is evidence that receptor dimerization/oligomeriza-
tion is a key event in Met activation (Banerjee et al., 2004;
Kong-Beltran et al., 2004; Prat et al., 1998). However, we
did not observe dimerization of the Met ectodomain upon
binding of InlB321 in solution. Furthermore, although both
crystal form I and II contain two Met741-InlB321 complexes
in the asymmetric unit, these dimeric assemblies appear
to be caused by crystal packing because the arrangement
differs markedly between the two crystal forms and the
contacts supporting them bear little specificity, arguing
against a potential physiological significance. Finally, we
found that mutant forms of InlB in which we disrupted
the major contact stabilizing the more plausible dimeric242 Cell 130, 235–246, July 27, 2007 ª2007 Elsevier Inc.assembly from crystal form I by insertion of an extra LRR
retained the ability to activate the Met receptor (data not
shown). Hence, how does InlB activate the Met receptor?
Full receptor activation requires the C-terminal GW
domains of the full-length protein in addition to the Met-
binding N-terminal domain. The present structure, the
biological activities of InlB321 and InlBfl, and the solution
behavior of these proteins in complex with Met928 provide
a framework for Met activation by InlB in which receptor
clustering plays the pivotal role. InlB exists in two forms,
noncovalently associated with the bacterial surface and
free in solution (Braun et al., 1997). It is currently unknown
which of these forms normally mediates bacterial inva-
sion, as both induce Met signaling (Bierne and Cossart,
2002). We have superimposed the structures of the
Met741-InlB321 complex and full-length InlB (Marino
et al., 2002; Figure 7A). This structure-based model seems
sterically plausible, as the proteins’ C termini associated
with the respective cell-surfaces point into almost oppo-
site directions, and suggests that several InlB molecules
could activate Met by receptor clustering while being
attached to Listeria via interaction between the GW
domains and lipoteichoic acid (Jonquieres et al., 1999).
Soluble InlBfl could activate Met by receptor clustering
as well, brought about by interaction of the GW domains
with HSPGs on the host cell surface (Figure 7B).
Two processes contribute to InlB-mediated Met activa-
tion, namely clamping of the receptor ectodomain and
receptor clustering. Using engineered variants of InlB,
these processes can be experimentally separated.
Clamping on its own is sufficient for partial activation of
Met as evident from receptor phosphorylation studies us-
ing InlB321, which can clamp but not cluster Met (Shen
et al., 2000; Figure 5C). Likewise, clustering of Met alone
can promote receptor activation in the absence of clamp-
ing. This is apparent from experiments in which InlB
constructs consisting of only Cap and LRR are artificially
clustered. For example, immobilization of Cap-LRR con-
structs on latex beads allows for efficient Met-mediated
entry of beads into cells that do not take up control beads
(Braun et al., 1999). Fusion of GW domains 2 and 3 to
a Cap-LRR fragment also yields a protein that can
induce Met phosphorylation, although one requiring
approximately 20-fold higher concentrations compared
with a version that additionally harbors the IR region
(Banerjee et al., 2004). This strongly suggests that in the
physiological context of the full-length protein both
processes cooperate to turn InlB into such a potent Met
agonist. In summary, activation of the Met receptor by
InlB occurs in three steps: (1) a first, high-affinity binding
event involving the LRR and Met Ig1, (2) receptor rigidifica-
tion via the secondary contact involving the IR and the Met
sema domain and finally, (3) receptor oligomerisation via
the GW domains, a process greatly enhanced by heparin
and, presumably, by heparan sulfate on the surface of tar-
get cells.
The Binding Site for the HGF/SF a Chain Overlaps
with the Secondary Interface for InlB
The structural aspects of the interaction between Met and
its natural ligand HGF/SF are still far from being com-
pletely understood, certainly owing, at least in part, to
problems in the amount and homogeneity of the sample
available. Proteins derived from bacteria are generally
easier to produce and handle than those of eukaryotic or
even mammalian origin. Bacterial virulence factors that
interact with eukaryotic host proteins, therefore, often
can be turned into useful tools to study not only the pro-
cess of infection but also the signaling pathway of the
host that is targeted. Our structural data in combination
with the data from competitive binding studies allow us
to draw conclusions pertinent to the interaction of the
natural ligand HGF/SF with the Met receptor.
The active form of HGF/SF is a two-chain protein pro-
duced by proteolytic cleavage of an inactive, single-chain
precursor (Figure 1C). The C-terminal b chain forms a sin-
gle domain homologous to serine proteases (SPH do-
main). The N-terminal a chain contains five additional do-
mains (an N-terminal [N] and four kringle [K1–K4] domains;
Birchmeier et al., 2003). Out of these six domains, three (N,
K1, and SPH) are responsible for HGF/SF binding to the
Sema domain of Met (Holmes et al., 2007; Stamos et al.,
2004). No competition for binding to Met would be ex-
pected between InlB321 and the SPH domain of HGF/SF,
as the binding sites are distant. The fact that we actually
did observe partial competition between InlB321 and
HGF/SF suggests that the N- and/or K1-binding sites
overlap, at least partially, with that for InlB IR on the bot-
tom and side faces around blade five of the b-propeller.Promiscuity of the Met Receptor: InlB Is Not
a Molecular Mimic of HGF/SF
The results presented here highlight two important differ-
ences in the mechanism of Met binding and activation by
InlB and the physiological ligand HGF/SF: (1) In the case of
HGF/SF, both the N-terminal (NK1) and the C-terminal
moiety (the SPH domain) display Met binding, and both
ends of the molecule bind the Sema domain (Holmes
et al., 2007; Stamos et al., 2004). Binding of InlB to Met,
in contrast, involves the N-terminal Cap-LRR-IR fragment
only (Banerjee et al., 2004; Shen et al., 2000) and crucially
depends on the Ig1 domain of Met; (2) Heparin has a mas-
sive effect on the oligomerisation of the InlBfl-Met928 com-
plex (Figure 6H) but not on the HGF/SF- Met928 complex
(Gherardi et al., 2003).
The ability of intracellular pathogenic bacteria to exploit
receptors on the host cell membrane for cell invasion
involves, in a number of instances, bacterial proteins
which are structural mimics of the physiological ligand
(Stebbins and Galan, 2001). The intracellular responses
elicited by InlB and HGF/SF are similar (Bierne and Cos-
sart, 2002; Shen et al., 2000), and HGF/SF can even sub-
stitute for InlB in inducing bacterial uptake (Banerjee et al.,
2004). However, our work clearly shows that InlB is not
a structural mimic of HGF/SF, that the two ligands bind
to different regions of the receptor, and that they employ
different molecular mechanisms for receptor activation.
L. monocytogenes thus relies on a robust, less-regulated
approach to achieve maximum receptor activation allow-
ing for efficient bacterial uptake during invasion. Finally,
our results demonstrate a striking promiscuity of Met to-
ward different ligands. Over evolutionary periods of time
L. monocytogenes has adapted to bind and activate Met
by a novel mechanism that may lead us an alternative
way to therapeutic approaches against cancer or infection
that take into account the Met stalk rather than focusing
merely on the Sema domain.
EXPERIMENTAL PROCEDURES
Protein Purification for Crystallization
Human Met constructs (Gherardi et al., 2003) were produced as
secreted, C-terminally His-tagged protein in CHO Lec8 (Met928 and
Met838) or in CHO Lec3.2.8.1 cells (Met741 and Met567). Cells were
grown in SMIF6 medium with 0.5% (Met838) or without FCS (Met928
and Met567) or in serum-free ProCHO5 medium (Met741). The yield
was about 1 to 2 mg of purified protein from 1 liter of culture. So far,
we have not been able to produce Met656, the variant with only one
Ig domain. During the production phase, cells were cultured at 32C.
Conditioned medium was concentrated and exchanged against 25
mM Na-phosphate pH 7.4, 150 mM NaCl using crossflow and a car-
tridge with 30 kDa cutoff. The protein was purified by affinity chroma-
tography over NiNTA superflow (Qiagen) followed by MonoS (GE
Healthcare) using a NaCl gradient (0.1 M to 1 M) in 50 mM Mes, pH
6.0. The protein was deglycosylated overnight at 20C using 5 mU of
EndoH (Calbiochem) per mg of protein in Na-acetate pH 5.5. Deglyco-
sylated protein was repurified over MonoS as above but using a shal-
low salt gradient. InlB321 was expressed as GST-fusion protein from
the pETM30 vector in E. coli BL21-CodonPlus(DE3) cells and purified
with a yield of about 20 mg per liter essentially as described (Schubert
et al., 2001) except that TEV protease was used for tag removal. TheCell 130, 235–246, July 27, 2007 ª2007 Elsevier Inc. 243
complex was formed by mixing Met741 with a molar excess of InlB321
and was purified using a Superdex200 HR 10/30 column (GE Health-
care) equilibrated in 10 mM Tris, pH 8.0, 50 mM NaCl. The complex
was concentrated to 5 mg/ml, and aliquots were frozen at 70C.
Crystallization and Data Collection
Initial crystals of the deglycosylated protein were grown from the pre-
cipitant synergy screen (Majeed et al., 2003). Diffraction-quality crys-
tals were obtained at 20C in 96-well sitting-drop plates with 2 ml
protein (5 mg/ml) + 1 ml reservoir. The reservoir (70 ml of 16.5% PEG
1500, 4.4% MPD, 0.1 M Tris, pH 8.5) was covered with 20 ml of Al’s
oil to slow down vapor diffusion. Crystals grew over several weeks
to a final size of about 100 3 100 3 50 mm. Crystals typically grew
as clusters and had to be broken apart for data collection. Crystals
were harvested in mother liquor supplemented with 15% glycerol
and were flash frozen in liquid nitrogen. Data were collected at ESRF
beamline ID23-2 in three wedges of 70–80 degrees from a single crys-
tal with 1 s exposure and 1 rotation per image. The crystal was trans-
lated between wedges because of radiation damage. All data were
indexed, integrated, and scaled with the XDS package (Kabsch,
1993). Data statistics are given in Table S1.
Structure Determination and Refinement
Crystal form I was solved by molecular replacement in Phaser (McCoy
et al., 2005). Crystal structures or homology models of individual
domains of the complex were used as search models: InlB321 (PDB
ID 1h6t; Schubert et al., 2001); Sema and PSI domain separately
(1shy; Stamos et al., 2004); homology models of Ig1 (1ux3) and Ig2
(2cew; Gherardi et al., 2003). All domains could be located with confi-
dence. A map calculated directly from the solution identified by Phaser
was used for correcting Sema, PSI, and InlB and for rebuilding the
homology model of Ig1 in coot (Emsley and Cowtan, 2004). The model
was completed by iterative building and refinement. The electron den-
sity for domain Ig2 was not continuous and did not allow rebuilding of
the homology model. Hence, Ig2 is not included in the final model. The
C2 cell contains two complexes in the asymmetric unit with transla-
tional NCS one-half along a and c leading to pseudocentering with
a noncrystallographic 2-fold parallel to the crystallographic 2-fold
axis. Tight NCS restraints on the individual domains were employed
throughout refinement in CNS (Brunger et al., 1998) and Refmac5
(Murshudov et al., 1997). After each cycle of rebuilding, simulated
annealing and individual B-factor refinement was carried out in CNS
followed by TLS and restrained refinement in Refmac5. Final steps
of refinement were carried out in Phenix (Adams et al., 2004) using sim-
ulated annealing and tight NCS. B-factors were modeled solely via TLS
refinement with 12 TLS groups, one for InlB321 and one for each Met
domain. We did not refine B-factors individually, as this caused only
a marginal drop in Rfree along with a significant drop in Rwork. The
same free-R set was kept in all programs. Refinement statistics are
given in Table S2.
Interface analysis and calculation of buried surface areas were
carried out using the PISA server (Krissinel and Henrick, 2005). The
electrostatic potential was calculated using APBS (Baker et al.,
2001). Domain motions were analyzed with Dyndom (Hayward and
Berendsen, 1998). Figures were prepared with PyMol (DeLano, 2002).
Purification of Full-Length InlB
Mature InlB (residues 36–630) was expressed from the vector pETM30
in E. coli BL21-CodonPlus(DE3) cells at 37C for 4 hr and was purified
by affinity chromatography using glutathione-sepharose. InlB was
cleaved from the tag with TEV in 50 mM Tris, pH 8.0, 150 mM NaCl,
1 mM DTT. The protein was then purified over MonoQ. To remove re-
maining nucleic acids, the protein was further purified over MonoS in
50 mM Hepes, pH 7.9, 0.2 M NaCl, 1 mM DTT with a linear salt gradi-
ent. The yield was about 0.5 mg of purified protein per liter. Monodis-
persity of the protein was verified by dynamic light scattering.244 Cell 130, 235–246, July 27, 2007 ª2007 Elsevier Inc.Analytical Ultracentrifugation
Sedimentation velocity analysis was performed using a Beckman
An60Ti rotor in a ProteomeLab XL-A ultracentrifuge. All runs were at
20C at speeds of 30,000, 45,000, 50,000, and 60,000 rev.min1 (as
appropriate to the sample) and scanning at 280 nm at the shortest pos-
sible time intervals (1.5 min). Protein samples were in 0.05 M Tris-Cl,
0.1 M NaCl, pH 8.0 (InlBfl and Met928) or in 0.02 M Tris-Cl, 0.1 M NaCl,
pH 8.0 (InlB321-Met928 and InlBfl-Met928 complexes) and were studied
at the concentrations given in the legend to Figure 6. Data were ana-
lyzed with DC/DT+ v.2.0.7 (Philo, 2006) to give sedimentation coeffi-
cients and, in simple cases, Mr, using partial specific volumes and sol-
vent parameters calculated (Laue et al., 1992) with SEDNTERP (Hayes
et al., 2006). Due to the complexity of the mixtures of aggregates in
many cases, results are shown as plots of dc/dt against s20,w since
these are directly derived from the data with no assumption about
boundary shape.
Met Activation
Phosphorylation of Erk1/2 was studied in Vero (African green monkey
kidney) cells using established procedures (Holmes et al., 2007; Rubin
et al., 2001) except that lysis buffer contained phosphatase inhibitor
cocktail 2 (Sigma P5726). Activated and total Erk1/2 were detected
with mouse monoclonal (Sigma M8159) or rabbit polyclonal (Promega
V114A) antibodies followed by HRP-conjugated secondary antibodies
and HRP substrate. Scattering of MDCK colonies (Stoker et al., 1987)
in response to truncated or full-length InlB or HGF/SF was assessed by
phase contrast micrography 18–24 hr after addition of test proteins
using a Leitz IRB55 microscope equipped with a Hamamatsu C5810
3CCD digital camera. DNA synthesis assays were carried out on the
MK keratinocyte cell line (Holmes et al., 2007).
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
two figures, and two tables and can be found with this article online
at http://www.cell.com/cgi/content/full/130/2/235/DC1/.
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